3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Philadelphia Chromosome
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Blast Crisis
1
Interventions
pembrolizumab
1
fludarabine
1
Everolimus
1
Cyclophosphamide
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thymus Neoplasms
×
bosutinib
×
90 days
×
Clear all
No trials found.